U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H16ClNO2S.H2O4S
Molecular Weight 419.9
Optical Activity ( + )
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CLOPIDOGREL BISULFATE

SMILES

OS(O)(=O)=O.COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=CC=CC=C3Cl

InChI

InChIKey=FDEODCTUSIWGLK-RSAXXLAASA-N
InChI=1S/C16H16ClNO2S.H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;1-5(2,3)4/h2-5,7,9,15H,6,8,10H2,1H3;(H2,1,2,3,4)/t15-;/m0./s1

HIDE SMILES / InChI
Molecular Formula C16H16ClNO2S
Molecular Weight 321.822
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED
Molecular Formula H2O4S
Molecular Weight 98.078
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:37:34 UTC 2023
Edited
by admin
on Fri Dec 15 15:37:34 UTC 2023
Record UNII
08I79HTP27
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CLOPIDOGREL BISULFATE
MART.   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
USAN  
Official Name English
METHYL (+)-(S)-.ALPHA.-(O-CHLOROPHENYL)-6,7-DIHYDROTHIENO(3,2-C)PYRIDINE-5(4H)-ACETATE, SULPHATE (1:1)
Common Name English
CLOPIDOGREL BISULFATE COMPONENT OF DUOCOVER
Brand Name English
CLOPIDOGREL-BMS
Brand Name English
CLOPIDOGREL HYDROGEN SULPHATE
EMA EPAR  
Common Name English
CLOPIDOGREL TEVA
Brand Name English
CLOPIDOGREL-BGR
Brand Name English
PLAVIX
Brand Name English
CLOPIDOGREL BISULFATE [USP-RS]
Common Name English
CLOPIDOGREL BMS
Brand Name English
CLOPIDOGREL BISULPHATE
Common Name English
CLOPIDOGREL HYDROGEN SULFATE [MI]
Common Name English
CLOPIDOGREL HYDROGEN SULFATE [EP MONOGRAPH]
Common Name English
Clopidogrel bisulfate [WHO-DD]
Common Name English
CLOPIDOGREL RATIOPHARM
Brand Name English
CLOPIDOGREL HYDROGEN SULFATE [EMA EPAR]
Common Name English
ISOCOVER
Brand Name English
CLOPIDOGREL (AS BISULFATE)
Common Name English
PIDOGREL
Brand Name English
CLOPIDOGREL BISULFATE [ORANGE BOOK]
Common Name English
CLOPIDOGREL BISULFATE [USP MONOGRAPH]
Common Name English
THIENO(3,2-C)PYRIDINE-5(4H)-ACETIC ACID, .ALPHA.-(2-CHLOROPHENYL)-6,7-DIHYDRO-, METHYL ESTER, (S)-, SULFATE (1:1)
Common Name English
CLOPIDOGREL (AS HYDROGEN SULFATE)
Common Name English
CLOPIDOGREL HYDROGEN SULPHATE [EMA EPAR]
Common Name English
CLOPIDOGREL BISULFATE COMPONENT OF DUOPLAVIN
Brand Name English
CLOPIDOGREL ZENTIVA
Brand Name English
CLOPIDOGREL/ACETYLSALICYCLIC ACID TEVA COMPONENT CLOPIDOGREL BISULFATE
Brand Name English
CLOPIDOGREL BISULFATE [MART.]
Common Name English
CLOPIDOGREL SULFATE [JAN]
Common Name English
SR-25990C
Code English
SR 25990C
Code English
CLOPIDOGREL BISULFATE [USAN]
Common Name English
DUOCOVER COMPONENT CLOPIDOGREL BISULFATE
Brand Name English
METHYL (+)-(S)-.ALPHA.-(O-CHLOROPHENYL)-6,7-DIHYDROTHIENO(3,2-C)PYRIDINE-5(4H)-ACETATE, SULFATE (1:1)
Common Name English
DUOPLAVIN COMPONENT CLOPIDOGREL BISULFATE
Brand Name English
THIENO(3,2-C)PYRIDINE-5(4H)-ACETIC ACID, .ALPHA.-(2-CHLOROPHENYL)-6,7-DIHYDRO-, METHYL ESTER, (S)-, SULPHATE (1:1)
Common Name English
CLOPIDOGREL HYDROGEN SULFATE
EMA EPAR   EP   MI  
Common Name English
CLOPIDOGREL BISULFATE COMPONENT OF CLOPIDOGREL/ACETYLSALICYCLIC ACID TEVA
Brand Name English
CLOPIDOGREL BISULFATE [VANDF]
Common Name English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS PLAVIX (AUTHORIZED: ATRIAL FIBRILLATION)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL TEVA (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS PLAVIX (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL TEVA (AUTHORIZED: STROKE)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
NCI_THESAURUS C80483
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL ZENTIVA (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS ZYLLT (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS PLAVIX (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL TEVA (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS ZYLLT (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS ZYLLT (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL-BMS (WITHDRAWN: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS ZYLLT (AUTHORIZED: STROKE)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL ZENTIVA (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS ISOCOVER (AUTHORIZED: ATRIAL FIBRILLATION)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS ISCOVER (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL RATIOPHARM (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS DUOCOVER (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL ZENTIVA (AUTHORIZED: STROKE)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL-BMS (WITHDRAWN: STROKE)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS DUOPLAVIN (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL ZENTIVA (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS PLAVIX (AUTHORIZED: STROKE)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL/ACETYLSALICYLIC ACID (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL-BGR (AUTHORIZED: STROKE)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL-BMS (WITHDRAWN: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS DUOPLAVIN (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL BMS (WITHDRAWN: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL RATIOPHARM (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL/ACETYLSALICYCLIC ACID TEVA (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL RATIOPHARM (AUTHORIZED: STROKE)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS DUOCOVER (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
EMA ASSESSMENT REPORTS ISCOVER (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
Code System Code Type Description
CAS
120202-66-6
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
PRIMARY
MERCK INDEX
m3655
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
PRIMARY Merck Index
RXCUI
236991
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
PRIMARY RxNorm
SMS_ID
100000092025
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
PRIMARY
ChEMBL
CHEMBL1771
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
PRIMARY
CHEBI
3759
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
PRIMARY
FDA UNII
08I79HTP27
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
PRIMARY
EVMPD
SUB12483MIG
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
PRIMARY
DAILYMED
08I79HTP27
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
PRIMARY
CAS
135046-48-9
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
NON-SPECIFIC STEREOCHEMISTRY
EPA CompTox
DTXSID601016080
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
PRIMARY
NCI_THESAURUS
C2673
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
PRIMARY
RS_ITEM_NUM
1140430
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
PRIMARY
PUBCHEM
115366
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
PRIMARY
DRUG BANK
DBSALT000029
Created by admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
PRIMARY
Related Record Type Details
Structure of CLOPIDOGREL
PARENT -> SALT/SOLVATE
Structure of CLOPIDOGREL BISULFATE, (R)-
ENANTIOMER -> ENANTIOMER
Related Record Type Details
Structure of (1R)-1-(2-CHLOROPHENYL)-2-METHOXY-2-OXOETHYL (.ALPHA.S)-.ALPHA.-(2-CHLOROPHENYL)-6,7-DIHYDROTHIENO(3,2-C)PYRIDINE-5(4H)-ACETATE
IMPURITY -> PARENT
Structure of CLOPIDOGREL CARBOXYLIC ACID
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of CLOPIDOGREL PYRIDINIUM
IMPURITY -> PARENT
Structure of Methyl (αR)-α-(2-chlorophenyl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-acetate
IMPURITY -> PARENT
Structure of Clopidogrel pyridinium, (+/-)-
IMPURITY -> PARENT
Structure of Methyl (αS)-α-(2-chlorophenyl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-acetate
IMPURITY -> PARENT
Structure of Methyl α-(2-chlorophenyl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-acetate
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Related Record Type Details
Structure of CLOPIDOGREL
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966